Follow the 오스코텍 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 오스코텍 has recorded 2 insider filings. Market capitalisation: €1,174.5bn. The latest transaction was filed on 9 April 2026 (Sale). Among the most active insiders: 타이거자산운용투자일임. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
OscoTech is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development of innovative treatments and therapeutic solutions.